Applied Genetic Technologies Corp
AGTCDelisted Dec 1, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001273636
Applied Genetic Technologies Corp was delisted on Dec 1, 2022; its insiders filed their last Form 4 on Dec 1, 2022; 45 institutions reported holding it in 13F filings for Q3 2022, worth $3.34M in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Applied Genetic Technologies Corp changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 82 | 71 | −11 |
| Shares | 18.6M | 13.9M | −4.62M (−24.9%) |
| Value | $93.3M | $53.9M | −$39.5M (−42.3%) |
New holders (13)
Institutions that held Applied Genetic Technologies Corp at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ergoteles LLC | 186,000 | $727.0K | 0.02% |
| Gsa Capital Partners LLP | 125,090 | $489.0K | 0.06% |
| HRT Financial LP | 125,098 | $489.0K | 0.00% |
| Knoll Capital Management, LLC | 100,000 | $391.0K | 0.20% |
| Tibra Equities Europe Ltd | 78,100 | $305.0K | 0.09% |
| Jump Financial, LLC | 41,100 | $161.0K | 0.02% |
| LMR Partners LLP | 24,664 | $96.0K | 0.00% |
| ACT Capital Management, LLC | 20,000 | $79.0K | 0.04% |
| Personal Cfo Solutions, LLC | 17,776 | $70.0K | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 10,004 | $39.0K | 0.01% |
| Godsey & Gibb Associates | 500 | $2.00K | 0.00% |
| Aspire Private Capital, LLC | 200 | $1.00K | 0.00% |
| FMR LLC | 2 | $0 | 0.00% |
Sold out (24)
Institutions that held Applied Genetic Technologies Corp at the end of Q1 2021 and filed for Q2 2021 without it.